BioSpace News Archive

Pharm Country

US WorldMeds and Salix Announce U.S. Launch of LUCEMYRA™ (lofexidine) 0.18 Mg Tablets

First and only FDA-approved, non-opioid medication indicated for mitigation of opioid withdrawal symptoms is now available for prescription

August 6, 2018
·
9 min read
Genetown

Bruker Announces Ultra-High Field NMR Orders from Major NMR Infrastructure Investment in the UK

Investment of £20 Million for Eight UK Universities Includes Two 1 GHz Systems

August 6, 2018
·
4 min read
Business

Henry Schein Reports Record Second Quarter 2018 Financial Results

GAAP diluted EPS of $0.92 increased by 7.0% over prior-year GAAP diluted EPS

August 6, 2018
·
60 min read
Business

Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers

Exclusive license agreement potentially worth more than $120 million in addition to royalties

August 6, 2018
·
4 min read
Biotech Bay

Protagonist Therapeutics Secures $22 Million Equity Financing

The transaction is expected to close on Aug. 8, 2018.

August 6, 2018
·
3 min read
Drug Development

Final Results from the Protagonist PROPEL Study Support Further Clinical Development of PTG-100 for the Treatment of Ulcerative Colitis

Independent blinded re-read of endoscopies provides signal of clinical efficacy and identifies human error in initial reads provided by contract research organization

August 6, 2018
·
8 min read
Business

Gamida Cell Expands its Leadership Team with the Appointment of Jaren Madden as Vice President, Investor Relations and Corporate Communications

Ms. Madden brings nearly 20 years of strategic communications experience to this new role at Gamida Cell, and will be responsible for the company’s engagement with the investment community as well as leading Gamida Cell’s media relations activities.

August 6, 2018
·
2 min read
Business

Casma Therapeutics Expands Executive Team with Appointment of Two Senior Vice Presidents

Jeffrey Saunders, Ph.D., Casma’s new senior vice president of drug discovery, and Daniel Ory, M.D., as senior vice president of translational medicine.

August 6, 2018
·
3 min read
Business

Alpine Immune Sciences Strengthens Leadership Team with Appointment of Mark Litton as President and Chief Operating Officer

Dr. Litton joins Alpine from Alder BioPharmaceuticals, where he has served as Chief Business Officer and Treasurer since co-founding the company in 2004.

August 6, 2018
·
5 min read
Job Trends

Alta Devices Powers Successful CubeSat Mission

Alta Devices Modular, Lightweight and Highly Efficient Solar Cells

August 6, 2018
·
7 min read